Evaluation of KRAS, NRAS and BRAF mutational status and microsatellite instability in early colorectal carcinomas invading the submucosa (pT1): towards an in-house molecular prognostication for pathologists?
- 1 November 2020
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 73 (11), 741-747
- https://doi.org/10.1136/jclinpath-2020-206496
Abstract
Aim We aimed to study the prognostic value of KRAS, NRAS, BRAF mutations and microsatellite stable (MSS)/instable (MSI) in the field of colorectal cancer invading the submucosa (ie, pT1 colorectal cancer (CRC)). Methods We led a case-control study in tumour samples from 60 patients with pT1 CRC with (20 cases) and without (40 cases) metastatic evolution (5 years of follow-up) which were analysed for KRAS, NRAS, BRAF mutations (Idylla testing and next generation sequencing, NGS) and MSS/MSI status (Idylla testing and expression of mismatch repair (MMR) proteins using immunohistochemistry). Results KRAS mutations were encountered in 11/20 (55%) cases and 21/40 (52.5%) controls (OR=1.11 (0.38 to 3.25), p=0.8548), NRAS mutations in 1/20 (5%) cases and 3/40 (7.5%) controls (OR=3.08 (0.62 to 15.39), p=0.1698) and BRAF mutations in 3/20 (15%) cases and 6/40 (15%) controls (OR=1.00 (0.22 to 4.5), p=1.00). A MSI status was diagnosed in 3/20 (15%) cases and 5/40 (12.5%) controls (OR=1.2353 (0.26 to 5.79), p=0.7885). Beyond the absence of significant association between the metastatic evolution and any of the studied molecular parameters, we observed a very good agreement between methods analysing KRAS, NRAS and BRAF mutations (Kappa value of 0.849 (0.748 to 0.95) between Idylla and NGS) and MSS/MSI (Idylla)-proficient MMR/deficient MMR (immunohistochemistry) status (Kappa value of 1.00). Conclusion Although being feasible using the fully automated Idylla method as well as NGS, the molecular testing of KRAS, NRAS, BRAF and MSS/MSI status does not seem useful for prognostic purpose in the field of pT1 CRC.Keywords
This publication has 33 references indexed in Scilit:
- A large-scale multicenter study of long-term outcomes after endoscopic resection for submucosal invasive colorectal cancerEndoscopy, 2013
- Predictors for lymph node metastasis in T1 colorectal cancerEndoscopy, 2012
- KRAS mutation and microsatellite instability: two genetic markers of early tumor development that influence the prognosis of colorectal cancer.Annals of Surgical Oncology, 2009
- Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancersColorectal Disease, 2008
- Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancersCarcinogenesis: Integrative Cancer Research, 2006
- Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated typeJournal of Clinical Pathology, 2006
- Interobserver variability in the pathological assessment of malignant colorectal polypsBritish Journal of Surgery, 2004
- Lymph node involvement and tumor depth in rectal cancersDiseases of the Colon & Rectum, 1997
- Management of early invasive colorectal cancerDiseases of the Colon & Rectum, 1995
- Early (microinvasive) colorectal carcinomaInternational Journal of Colorectal Disease, 1986